Skip to main content
. 2014 Mar 19;348:g1996. doi: 10.1136/bmj.g1996

Table 5.

 Hazard ratios (95% confidence interval) for age adjusted associations between defined daily doses (DDDs) of study drug (versus no study drugs) and mortality before and after adjusting for other potential confounders*, for exposure restricted to receipt of study drugs in first year after recruitment only

DDDs No of patients Age adjusted hazard ratio (95% CI) P value Fully adjusted* hazard ratio (95% CI) P value
All study drugs:
 0 69 418 1.00 1.00
 1-30 6648 2.47 (2.34 to 2.60) <0.001 2.55 (2.42 to 2.69) <0.001
 31-60 2859 3.87 (3.66 to 4.15) <0.001 3.78 (3.54 to 4.04) <0.001
 61-90 1185 5.04 (4.62 to 5.50) <0.001 4.19 (3.84 to 4.58) <0.001
 ≥91 1971 5.59 (5.21 to 5.92) <0.001 4.51 (4.22 to 4.82) <0.001
Any DDDs 12 663 3.46 (3.34 to 3.59) <0.001 3.32 (3.19 to 3.45) <0.001
Benzodiazepines only:
 1-30 4625 2.71 (2.54 to 2.88) <0.001 2.78 (2.62 to 2.96) <0.001
 31-60 1414 5.17 (4.77 to 5.59) <0.001 4.62 (4.26 to 5.01) <0.001
 61-90 549 6.62 (5.91 to 7.42) <0.001 5.42 (4.84 to 6.08) <0.001
 ≥91 881 6.75 (6.18 to 7.34) <0.001 5.10 (4.67 to 5.58) <0.001
Any DDDs 7469 3.89 (3.73 to 4.06) <0.001 3.68 (3.52 to 3.85) <0.001
Z drugs only:
 1-30 858 2.39 (2.07 to 2.77) <0.001 2.36 (2.05 to 2.74) <0.001
 31-60 807 3.53 (3.08 to 4.04) <0.001 3.41 (2.98 to 3.91) <0.001
 61-90 278 4.58 (3.75 to 5.59) <0.001 3.66 (2.99 to 4.48) <0.001
 ≥91 492 4.83 (4.22 to 5.54) <0.001 3.90 (3.39 to 4.47) <0.001
Any DDDs 2435 3.50 (3.24 to 3.77) <0.001 3.19 (2.95 to 3.45) <0.001
Other study drugs only:
 1-30 976 1.93 (1.71 to 2.19) <0.001 1.86 (1.64 to 2.10) <0.001
 31-60 378 2.02 (1.67 to 2.43) <0.001 2.09 (1.73 to 2.51) <0.001
 61-90 154 2.92 (2.25 to 3.82) <0.001 2.46 (1.87 to 3.22) <0.001
 ≥91 175 3.34 (2.68 to 4.16) <0.001 2.65 (2.13 to 3.30) <0.001
Any DDDs 1683 2.18 (2.00 to 2.38) <0.001 2.06 (1.88 to 2.25) <0.001

*Age, sex, physical health problems (arthritis, asthma, cancer, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, diabetes, epilepsy, gastrointestinal disorders, hypertension, musculoskeletal disorders, anxiety disorders, sleep disorders, other (non-anxiety), psychiatric disorders, and prescriptions for non-study drugs.